1st Quarter - Report

SAREPTA THERAPEUTICS, INC. for SAREPTA THERAPEUTICS, INC.

Firm
Client
Income
—
Expenses
$270,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Duchenne Muscular Dystrophy and Rare Disease Patient Access to Treatments Newborn Screening for Rare Diseases

LobbyistCovered position, as disclosed
MADISON SMITH New Staff Assistant, Rep. Jerry Lewis; Staff Assistant, Rep. Ken Calvert

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Science/Technology SCI

Scientific Innovation in Healthcare Gene Therapies Artificial Intelligence and Data Governance

LobbyistCovered position, as disclosed
MADISON SMITH New Staff Assistant, Rep. Jerry Lewis; Staff Assistant, Rep. Ken Calvert

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.